Description
BridgeBio is hiring a full-time Skeletal Dysplasia Account Manager to lead the launch and commercial expansion of Infigratinib for achondroplasia across multiple territories in the Northeast United States. The role develops territory business plans, engages multidisciplinary healthcare providers and families, builds key-account relationships, supports compliance, and collaborates with medical, reimbursement, marketing, and other cross-functional teams. Candidates need 8–10 years of pharmaceutical or biotech experience, including 4+ years in rare disease, genetic disease, or skeletal dysplasia, along with a BS/BA, extensive travel willingness, product-launch experience, and AI fluency. The role offers a $155,000–$210,000 USD salary range for California-based candidates, plus health benefits, equity, and a hybrid work model.
